CORTISOLSUMMIT

Serial Number 98195923
602

Registration Progress

Application Filed
Sep 25, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

CORTISOLSUMMIT

Basic Information

Serial Number
98195923
Filing Date
September 25, 2023
Abandonment Date
August 2, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 15, 2024
Classes
044

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
Suite 1810
180 N LaSalle Street
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Aug 15, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Aug 15, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 1, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 10, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 28, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing health information; providing online information in the field of health; providing online information in the field of endocrine disorders; providing online information in the field of Cushing Syndrome

Additional Information

Pseudo Mark
CORTISOL SUMMIT

Classification

International Classes
044